Clinical Trial

The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
To compare the efficiency between surgery and radiotherapy after SHR-1316 (Adebrelimab)and platinum-containing doublet induction therapy for limited-stage small cell lung cancer
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-08-08.
Trial Details
NCT Number NCT05496166
Lead Sponsor Shanghai Pulmonary Hospital, Shanghai, China
Collaborators: Jiangsu HengRui Medicine Co., Ltd.
Conditions Limited Stage Small Cell Lung Cancer
Enrollment 348 participants
Start Date 2023-08-01
Primary Completion 2027-08-01 (estimated)
Study Completion 2030-08-01 (estimated)
Updated on ClinicalTrials.gov 2023-05-17